https://www.sciencedirect.com/science/article/pii/S1044579X17300913
Hematological malignancies including lymphoid and myeloid neoplasms can lead to  
account for ∼10% of all diagnosed cancer cases in 2016 in the United States.   
The disruption and misregulation of these processes
have the potential to lead to life-threatening hematological disorders